Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-04

Clinical Trial Update: Intravenous Ascorbic Acid Administration in Hysterectomy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on intravenous ascorbic acid administration in patients undergoing hysterectomy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ascorbic acid (intravenous) (ascorbic acid)

Snippet

Sponsor: Shahid Beheshti University | Conditions: Abdominal Hysterectomy | Phase 3 | Status: COMPLETED